| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ENTEROMEDICS INC | 33,334 | 5,000 | 0.00% | ||
| 2 | CHECK CAP LTD | 51,218 | 29,000 | 0.02% | ||
| 3 | CEL SCI CORP | 127,482 | 39,000 | 0.03% | ||
| 4 | GENVEC INC | 95,800 | 45,000 | 0.03% | ||
| 5 | CATALYST | 70,903 | 86,000 | 0.06% | ||
| 6 | Nivalis Therapeutics Inc | 15,000 | 122,000 | 0.08% | ||
| 7 | AVINGER INC | 30,800 | 147,000 | 0.10% | ||
| 8 | PALATIN TECHNOLOGIES INC COM | 257,193 | 162,000 | 0.11% | ||
| 9 | NEOS THERAPEUTICS INC COM | 38,873 | 256,000 | 0.18% | ||
| 10 | DEXTERA SURGICAL INC | 140,275 | 264,000 | 0.18% | ||
| 11 | NEURODERM LTD | 14,421 | 267,000 | 0.19% | ||
| 12 | AQUINOX PHARMACEUTICALS INC | 20,000 | 267,000 | 0.19% | ||
| 13 | CELYAD SA | 12,528 | 296,000 | 0.21% | ||
| 14 | IMMUNE DESIGN CORP | 40,000 | 303,000 | 0.21% | ||
| 15 | BLUEBIRD BIO INC COM | 6,000 | 407,000 | 0.28% | ||
| 16 | Pieris Pharmaceuticals | 223,325 | 408,000 | 0.28% | ||
| 17 | MINERVA NEUROSCIENCES INC COM | 33,100 | 467,000 | 0.33% | ||
| 18 | ARRAY BIOPHARMA INC | 69,300 | 468,000 | 0.33% | ||
| 19 | INNOCOLL HLDGS PLC | 100,000 | 581,000 | 0.40% | ||
| 20 | MASIMO CORP | 10,000 | 595,000 | 0.41% | ||
| 21 | SYNERON MEDICAL LTD | 85,947 | 615,000 | 0.43% | ||
| 22 | Ascendis Pharma | 30,750 | 618,000 | 0.43% | ||
| 23 | COGENTIX MED INC | 353,482 | 643,000 | 0.45% | ||
| 24 | CONCERT PHARMACEUTICALS INCORPORATED | 66,968 | 677,000 | 0.47% | ||
| 25 | DICERNA PHARMACEUTICALS INC | 119,300 | 701,000 | 0.49% | ||
| 26 | IRONWOOD PHARMACEUTICALS INC DBCV 2.250 6/1 | 600,000 | 717,000 | 0.50% | PRN | |
| 27 | ESSA Pharma | 195,496 | 733,000 | 0.51% | ||
| 28 | INOTEK PHARMACEUTICALS CORP | 600,000 | 794,000 | 0.55% | PRN | |
| 29 | SCYNEXIS INC | 213,250 | 825,000 | 0.57% | ||
| 30 | Exactech Inc | 31,636 | 855,000 | 0.60% | ||
| 31 | ZOGENIX INC | 79,538 | 909,000 | 0.63% | ||
| 32 | JOHNSON & JOHNSON | 9,400 | 1,110,000 | 0.77% | ||
| 33 | NOVADAQ TECHNOLOGIES INC | 101,841 | 1,178,000 | 0.82% | ||
| 34 | Stereotaxis Inc | 1,372,862 | 1,194,000 | 0.83% | ||
| 35 | EIGER BIOPHARMACEUTICALS INC | 90,000 | 1,205,000 | 0.84% | ||
| 36 | WINDTREE THERAPEUTICS INC | 480,833 | 1,231,000 | 0.86% | ||
| 37 | RIGEL PHARMACEUTICAL INC | 340,000 | 1,248,000 | 0.87% | ||
| 38 | REGULUS THERAPEUTICS INC COM | 421,500 | 1,391,000 | 0.97% | ||
| 39 | BioTelemetry Inc | 80,000 | 1,486,000 | 1.03% | ||
| 40 | ACHILLION PHARMACEUTICALS IN | 186,500 | 1,511,000 | 1.05% | ||
| 41 | SYNERGY PHARMACEUTICALS DEL | 274,563 | 1,513,000 | 1.05% | ||
| 42 | PROTALIX BIOTHERAPEUTICS INC | 2,500,000 | 1,525,000 | 1.06% | PRN | |
| 43 | UNIQURE NV | 203,907 | 1,560,000 | 1.09% | ||
| 44 | MACROGENICS INC | 54,200 | 1,621,000 | 1.13% | ||
| 45 | SPECTRANETICS CORP | 65,496 | 1,643,000 | 1.14% | ||
| 46 | DERMA SCIENCES ORD | 353,718 | 1,652,000 | 1.15% | ||
| 47 | CYTOKINETICS INC | 181,737 | 1,668,000 | 1.16% | ||
| 48 | BIOSPECIFICS TECHNOLOGIES CO | 39,704 | 1,813,000 | 1.26% | ||
| 49 | IMMUNOMEDICS INCORPORATED | 566,796 | 1,842,000 | 1.28% | ||
| 50 | RADIUS HEALTH INCORPORATED COM NEW | 36,854 | 1,993,000 | 1.39% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000037, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
